10m
Hosted on MSNLundbeck gains FDA fast track designation for MSA therapy amlenetugThe designation will provide Lundbeck with the possibility of rolling reviews and detailed guidance to streamline the drug ...
Research and development expenses were $12.6 million for the second quarter of fiscal 2025, compared with $12.0 million for the same period a year ago, with the increase primarily attributable to ...
Here's what to know about food recalls in the U.S., as a number of recalls targeting various food products were issued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results